# Measles and Rubella Vaccine Microneedle Patch Phase 1-2 Age De-escalation Trial

> **NCT04394689** · PHASE1,PHASE2 · COMPLETED · sponsor: **Micron Biomedical, Inc** · enrollment: 281 (actual)

## Conditions studied

- Measles
- Rubella
- Vaccination
- Healthy

## Interventions

- **BIOLOGICAL:** Measles Rubella Vaccine (MRV-SC)
- **BIOLOGICAL:** MRV-MNP
- **OTHER:** PLA-MNP
- **OTHER:** PLA-SC

## Key facts

- **NCT ID:** NCT04394689
- **Lead sponsor:** Micron Biomedical, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-19
- **Primary completion:** 2022-11-23
- **Final completion:** 2022-12-31
- **Target enrollment:** 281 (ACTUAL)
- **Last updated:** 2023-03-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04394689

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04394689, "Measles and Rubella Vaccine Microneedle Patch Phase 1-2 Age De-escalation Trial". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04394689. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*